The following data is part of a premarket notification filed by Alcon Laboratories, Inc. with the FDA for Infiniti.
Device ID | K021566 |
510k Number | K021566 |
Device Name: | INFINITI |
Classification | Unit, Phacofragmentation |
Applicant | ALCON LABORATORIES, INC. 6201 SOUTH FREEWAY Fort Worth, TX 76134 -2099 |
Contact | Michael Buenger |
Correspondent | Michael Buenger ALCON LABORATORIES, INC. 6201 SOUTH FREEWAY Fort Worth, TX 76134 -2099 |
Product Code | HQC |
Subsequent Product Code | HQR |
Subsequent Product Code | MLZ |
CFR Regulation Number | 886.4670 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-05-13 |
Decision Date | 2002-07-02 |
Summary: | summary |